Evidence map›Paper›PMID 35663304›Full record

ArticleFrontiers in endocrinology2022

Identification and Verification of Diagnostic Biomarkers for Glomerular Injury in Diabetic Nephropathy Based on Machine Learning Algorithms.

Hongdong Han, Yanrong Chen, Hao Yang, Wei Cheng, Sijing Zhang, Yunting Liu, Qiuhong Liu, Dongfang Liu, Gangyi Yang, Ke Li

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Biomarkers of Arginine Methylation in Diabetic Nephropathy: Novel Insights from Bioinformatics Analysis.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Co-Expression of MultipleInternational journal of molecular sciences · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hongdong HanDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Yanrong ChenDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Hao YangDepartment of Endocrinology and Neurology, Jiulongpo People's Hospital, Chongqing, China.
Wei ChengDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Sijing ZhangDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Yunting LiuDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Qiuhong LiuDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Dongfang LiuDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Gangyi YangDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Ke LiDepartment of Endocrinology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.
Dalian Medical University · CNSecond Affiliated Hospital of Chongqing Medical University · CNChongqing Medical University · CNChongqing Jiulongpo People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is regarded as the leading cause of end-stage renal disease worldwide and lacks novel therapeutic targets. To screen and verify special biomarkers for glomerular injury in patients with DN, fifteen datasets were retrieved from the Gene Expression Omnibus (GEO) database, correspondingly divided into training and testing cohorts and then merged. Using the limma package, 140 differentially expressed genes (DEGs) were screened out between 81 glomerular DN samples and 41 normal ones from the training cohort. With the help of the ConsensusClusterPlus and WGCNA packages, the 81 glomerular DN samples were distinctly divided into two subclusters, and two highly associated modules were identified. By using machine learning algorithms (LASSO, RF, and SVM-RFE) and the Venn diagram, two overlapping genes (PRKAR2B and TGFBI) were finally determined as potential biomarkers, which were further validated in external testing datasets and the HFD/STZ-induced mouse models. Based on the biomarkers, the diagnostic model was developed with reliable predictive ability for diabetic glomerular injury. Enrichment analyses indicated the apparent abnormal immune status in patients with DN, and the two biomarkers played an important role in the immune microenvironment. The identified biomarkers demonstrated a meaningful correlation between the immune cells' infiltration and renal function. In conclusion, two robust genes were identified as diagnostic biomarkers and may serve as potential targets for therapeutics of DN, which were closely associated with multiple immune cells.

Indexed as

Diabetes MellitusDiabetic NephropathiesAlgorithmsAnimalsBiomarkersHumansMachine LearningMiceBiomarkersbiomarkerdiabetic nephropathydiagnostic modelglomerular injurymachine learning algorithm

Identifiers

PMID35663304
PMCPMC9162431
OpenAlexW4280640234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.